<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362263">
  <stage>Registered</stage>
  <submitdate>19/03/2012</submitdate>
  <approvaldate>26/03/2012</approvaldate>
  <actrnumber>ACTRN12612000344897</actrnumber>
  <trial_identification>
    <studytitle>Intravitreal Steroid for Anterior Ischemic Optic Nerve disease.</studytitle>
    <scientifictitle>The effect of intravitreal triamcinolone on best corrected visual acuity (BCVA) and visual field in patients with non-arteritic anterior ischemic optic neuropathy.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Non-arteritic Anterior Ischemic Optic Neuropathy</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>An intravitreal injection of 4 mg/0.1ml triamcinolone acetonide</interventions>
    <comparator>observation with standard care</comparator>
    <control>Active</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>BCVA) according to the Snellen chart (converted to logMAR units) at twelfth week</outcome>
      <timepoint>twelfth week</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Mean deviation of automated perimetry 30-2 on a Humphrey field analyzer</outcome>
      <timepoint>twelfth week</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Retinal nerve fiber layer thickness using Optical Coherence Tomography (OCT)</outcome>
      <timepoint>twelfth week</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>- acute painless visual loss 
- localized optic disc edema
- no associated symptoms (; i.e. headache/scalp tenderness/jaw claudication)
- unilateral involvement with the normal fellow eye
- no previous attack or treatment</inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>- ocular and/or orbital infection
- other ocular disease that might interfere with visual acuity and/ or the visual field</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>- All of the patients were randomized into two groups: one treated with IVTA while the other was simply observed.  
- allocation concealment by sealed opaque envelopes</concealment>
    <sequence>Permuted block randomization</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 3</phase>
    <anticipatedstartdate>1/04/2012</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>20</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Thailand</country>
      <state>Khon Kaen</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Khon Kaen University</primarysponsorname>
    <primarysponsoraddress>Faculty of Medicine, Khon Kaen University, Mitraparp Road, Muang, Khon Kaen, Thailand 40002</primarysponsoraddress>
    <primarysponsorcountry>Thailand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Khon Kaen University</fundingname>
      <fundingaddress>Faculty of Medicine, Khon Kaen University, Mitraparp Road, Muang, Khon Kaen, Thailand 40002</fundingaddress>
      <fundingcountry>Thailand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study was to determine the effect of intravitreal triamcinolone acetonide (IVTA), compared to careful observation, in restoration of optic nerve functions.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Human Ethic Commitee of Khon Kaen University</ethicname>
      <ethicaddress>Faculty of Medicine, Khon Kaen University, Mitraparp Road, Muang, Khon Kaen, Thailand 40002</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Thailand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Kitthisak Kitthaweesin</name>
      <address>Department of Ophthalmology
Faculty of Medicine
Khon Kaen University
Khon KaeFaculty of Medicine, Khon Kaen University, Mitraparp Road, Muang, Khon Kaen, Thailand 40002</address>
      <phone>6643348383</phone>
      <fax>6643348383</fax>
      <email>kitthisak@hotmail.com</email>
      <country>Thailand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Kitthisak Kitthaweesin</name>
      <address>Department of Ophthalmology
Faculty of Medicine, Khon Kaen University, Mitraparp Road, Muang, Khon Kaen, Thailand 40002</address>
      <phone>6643348383</phone>
      <fax>6643348383</fax>
      <email>kitthisak@hotmail.com</email>
      <country>Thailand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Kitthisak Kitthaweesin</name>
      <address>Department of Ophthalmology
Faculty of Medicine
Khon Kaen University
Khon Kaen</address>
      <phone>6643348383</phone>
      <fax>6643348383</fax>
      <email>kitthisak@hotmail.com</email>
      <country>Thailand</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>